Citigroup’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
DGM
Citigroup's GMAB Position: Q3 2026 in Review
Citigroup reduced its Genmab (GMAB) stake by 12% in Q3 2026, selling an estimated $104K and leaving 24,245 shares worth $865K. The position accounts for ﹤0.01% of the portfolio, ranked #3428.
Citigroup first reported a position in GMAB in Q3 2019 and has held it in 29 quarters since. The position peaked at $3.82M in Q4 2020. 333 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.
- Citigroup held 24,245 shares of Genmab worth $865K as of Q3 2026.
- Citigroup sold 3,286 Genmab shares in Q3 2026, an estimated $104K.
- Genmab made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #3428 holding.
- Citigroup first reported a position in Genmab in Q3 2019 and has held it in 29 quarters since.
- Citigroup's Genmab position peaked at $3.82M in Q4 2020.
- 333 funds tracked by Wall St. Rank held Genmab as of Q3 2026.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.